Cellectis (CLLS) Balance Sheet: Assets & Liabilities

Cellectis (CLLS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cellectis reported total assets of $324.72M and total liabilities of $248.82M. Shareholders' equity was $75.90M, down 42.1% from $131.03M a year earlier. Total debt stood at $119.90M against $208.66M in cash and short-term investments, a net cash position of $88.76M. That puts debt-to-equity at 1.58, compared with 0.43 a year earlier.

Cellectis Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cellectis S.A. (CLLS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	63.58	143.25	136.71	89.79	185.64	241.15	360.91	451.89	296.98
Short-Term Investments	145.08	117.06	67.11	7.91	0.50	27.09	0.00	0.00	0.00
Cash & Short-Term Investments	208.66	260.31	136.71	97.70	185.64	253.24	360.91	451.89	296.98
Accounts Receivable	22.20	6.71	0.57	0.77	20.36	19.19	15.29	22.07	4.57
Inventory	0.00	0.00	0.00	0.00	0.00	1.61	2.90	0.28	0.25
Other Current Assets	5.38	5.53	7.72	0.54	9.67	14.11	12.42	13.41	11.30
Total Current Assets	236.24	287.07	233.01	143.81	225.43	315.36	391.52	487.64	323.22
Non-Current Assets
Property, Plant & Equipment (Net)	62.45	75.86	92.74	107.90	148.27	145.52	69.32	10.04	7.23
Long-Term Investments	5.09	7.52	7.85	8.79	6.52	7.01	5.52	1.89	1.00
Intangible Assets	0.54	1.12	0.67	0.72	1.85	1.58	1.11	1.27	1.43
Other Non-Current Assets	20.03	11.98	7.85	0.00	0.00	0.00	5.52	0.00	0.10
Total Non-Current Assets	88.48	96.48	101.27	117.41	156.65	154.11	75.95	13.20	9.66
Total Assets	324.72	383.54	334.27	261.22	382.08	469.47	467.47	500.84	332.88
Current Liabilities
Accounts Payable	17.28	18.66	19.07	21.46	23.76	24.61	29.26	15.88	9.46
Short-Term Debt	18.16	4.84	5.16	4.97	2.25	6.70	1.07	0.33	0.02
Current Portion of Long-Term Debt	10.46	16.13	5.29	5.09	2.35	-	-	-	-
Accrued Liabilities	1.17	0.83	1.74	9.42	0.87	13.05	-	-	-
Deferred Revenue	96.80	112.16	110.33	0.06	0.30	0.45	20.03	20.75	26.06
Other Current Liabilities	13.51	10.10	10.22	15.68	13.73	7.21	12.11	9.61	7.99
Total Current Liabilities	145.75	166.27	155.14	63.00	49.35	52.02	62.60	46.87	43.53
Non-Current Liabilities
Long-Term Debt	101.74	50.88	49.13	13.57	20.03	24.22	46.54	1.02	0.01
Deferred Tax Liabilities	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	1.33	1.12	2.36	6.96	4.70	8.63	2.86	2.68	3.43
Total Non-Current Liabilities	103.07	86.24	94.43	72.28	96.25	108.61	49.40	3.70	3.44
Total Liabilities	248.82	252.51	249.58	135.28	145.60	160.63	112.00	50.57	46.98
Stockholders' Equity
Common Stock	5.90	5.89	4.37	2.96	2.95	2.79	2.77	2.77	2.37
Retained Earnings	-334.13	-329.61	-405.77	-439.50	-698.33	-587.04	-508.48	-405.32	-351.30
Accumulated Other Comprehensive Income	-33.32	-39.54	-36.69	-28.61	-18.02	-4.09	-22.64	-16.67	1.98
Additional Paid-in Capital	437.45	494.29	522.79	583.12	934.70	872.13	843.48	828.53	613.74
Minority Interest	0.00	0.00	0.00	7.97	15.18	25.05	40.35	40.97	19.11
Shares Outstanding	100.34	72.09	71.75	45.68	45.48	-	-	-	-
Total Stockholders' Equity	75.90	131.03	84.70	117.97	236.47	308.85	315.12	409.30	266.79
Total Liabilities & Equity	324.72	383.54	334.27	261.22	382.08	469.47	467.47	500.84	332.88

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cellectis Balance Sheet

How much debt does Cellectis have?

Cellectis had total debt of $119.90M as of Dec 31, 2025, against $208.66M in cash and short-term investments. Its debt-to-equity ratio was 1.58. Total debt was $55.72M a year earlier.

What are Cellectis's total assets?

Cellectis reported total assets of $324.72M as of Dec 31, 2025, down 15.3% from $383.54M a year earlier. Total liabilities were $248.82M.

What is Cellectis's shareholders' equity?

Cellectis's shareholders' equity was $75.90M as of Dec 31, 2025, or about $0.76 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition